Cost –Utility Analysis of Two Budesonide Inhalers For Treatment of Asthma In Children In Russian Federationdoi:10.1016/j.jval.2017.08.1498Makarova, EYagudina, RKulikov, AValue in Health
order to perform the search for the most suitable and representative articles, key words were selected (“asthma”, “cost-effectiveness”, “cost-utility”, “QALY”, “cost-benefit”, “economic impact of asthma” “healthcare cost”, “asthma treatment” and “work productivity with asthma”...
Kiowa Rix, 27, of Warren, Michigan, found herself with a $500 out-of-pocket price tag for her son Lucas’ inhaler — Flovent, from GSK — in February, when her insurance stopped covering the medication. The 6-year-old has severe asthma and needs to use an inhal...
According to the Korean Academy of Asthma, Allergy and Clinical Immunology, asthma's direct and indirect costs are estimated to be around 4 trillion won ($2.85 billion). Patients with severe asthma have a 44.4 percent job interruption rate due to the threat of acute exacerbations. Acute exacerba...
In an open randomised parallel-group study, 1004 patients with asthma in 7 countries were randomised to receive asthma treatment via 2 different kinds of inhalers: an aerosol pressurised metered dose inhaler (pMDI) and a dry powder inhaler (Turbuhaler). The patients were treated for 52 weeks wi...
Objectives A pharmacy asthma care program in Australia, which included specific education on asthma and asthma medication, trigger factors, use of inhalers, and medication adherence, as well as goal setting and patient review aspects, assessed the impact of a community pharmacy asthma service on the...
Studies published in the Annals of American Thoracic Society and the Journal of Allergy and Clinical Immunology estimated the annual costs per person for asthma treatment between $1,800 and $4,900 for inhalers and medications prescriptions alone, including direct costs (e.g. medicine and visits ...
The Cost of Asthma Summary Asthma is a major public health problem in developed countries, where it consumes a large and increasing share of scarce health resources. Ideally, medical management should be both optimal in terms of improving the patient’s quality of life, and cost-effective for ...
Respondents to the survey provided data on the number of times they took oral steroids, inhalers for quick relief/rescue, and long-term maintenance medications for the management of asthma symptoms in the previous 12 months. They also reported the number of times they visited the emergency room...
OBJECTIVES Older patients with asthma or chronic obstructive pulmonary disease are particularly susceptible to exacerbations that may be associated with incorrect use of inhalers. Educational programs with inhaler technique review seem to be effective, but no studies have addressed their cost〆ffecti...